Escitalopram in Depressive Patients With Acute Coronary Artery Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Depressive DisorderCoronary Disease
Interventions
DRUG

Escitalopram

Study medication will be provided as 1 tablet of escitalopram 5mg/day or 1 or 2 tablets of escitalopram 10mg/day, and matched placebo. The initial dose of escitalopram was 10mg/day generally, but 5mg/day for those aged 65 or over and with hepatic dysfunction. After the 2nd evaluation, the treatment doses are determined by the investigators' clinical decision considering the severity of depression and tolerability of drug. Drugs are taken once daily per orally within 30 min after the supper meal.

DRUG

Placebo

Placebo medication will be provided as matched 1 tablet of escitalopram 5mg/day or 1 or 2 tablets of escitalopram 10mg/day.

Trial Locations (1)

501-757

Chonnam National University Hospital, Gwangju

All Listed Sponsors
collaborator

H. Lundbeck A/S

INDUSTRY

lead

Chonnam National University Hospital

OTHER

NCT00419471 - Escitalopram in Depressive Patients With Acute Coronary Artery Syndrome | Biotech Hunter | Biotech Hunter